Aditxt (ADTX) announced that its acquisition target, Evofem Biosciences (EVFM), has secured voting agreements with certain of its investors to ensure they will vote in favor of the merger proposal at Evofem’s upcoming Special Meeting of Stockholders.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADTX:
- Aditxt, Inc. Focuses on Growth Amid Nasdaq Compliance
- Aditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
- Appili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
- Aditxt Enters Major Investment Agreement with Evofem
- Aditxt CEO Clarifies NASDAQ Compliance and Capital Strategy
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue